Download pharm 23 [4-20

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Electrocardiography wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Amiodarone wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Ventricular fibrillation wikipedia , lookup

Transcript
Chapter 23
Cardiac Rhythm Learning Objectives
1.
What is the greatest extent of depolarization in the SA node? What are the three stages of the
SA nodal cycle?
 -60 mV, at which point the phases begin, starting with…
 Phase 4: slow ramping up of depolarization; “inward current” (If) and outward K+ current (IK1)
 Phase 0: rapid depolarization mediated by voltage-gated Ca++ channels, and some Na+ too
 Phase 3: repolarization due to opening of K+ channels
2. What are the five phases of ventricular myocyte current?
 Phase 4: resting just above -94 mV
 Phase 0: INa
 Phase 1: early repolarization; opening of K+ channels (Ito)
 Phase 2: plateau; balance between Ca++ currents (ICa.T & ICa.L) and K+ currents (IK, IK1, Ito)
 Phase 3: late repolarization;decrease in Ca+ current and increase in K+ current
3.
What determines the myocyte refractory period?
 The time it takes for Na+ channels to reset
4. Phase 2 Ca++ channels are sensitive to block by dihydropyridines, benzothiazepines, and
phenylalkylamines
5.
What is “afterdepolarization?” What drugs trigger early afterdepolarizations? What can these
lead to?
 When a normal action potential triggers extra abnormal depolarizations—due to abnormal
Ca++ current in the plateau phase (2) or Na+ current in phase 3
i. Delayed repolarization occurs just after completion of repolarization
 Drugs that prolong the QT interval, like class IA and III antiarrhythmics
 Torsades de pointes, an emergency which can end in fibrillation and death
6.
What are the results of an accessory tract pathway?
 Wider QRS complex, early ventricular upstroke, re-entrant loops and tachyarrhymthias
7.
What does state-dependent ion channel block mean?
 Na+ channel blockers (class I) tend to associate with channels during the open and inactive
states, not with the resting/closed state
 This allows drugs to preferentialy act on ischemic/irritable tissue preferentially and block a
arrhythmogenic focus at its source
8.




9.
What ion channel or receptor does each of the four classes of antiarrhythmics block?
I = Na+
II = β-adrenergic
III = K+
IV = Ca++
[Nancy βakes Killer Cakes]
What do Class I antiarrhythmics do? What are two general concerns you should have?



Decrease automaticity in SA nodal cells by shifting threshold potential positively and reducing
slope of (atrial!) phase 4 (depolarization)
Decrease heart rate; Greater voltage needed for defibrillaors
Also increase refractory period and slow conduction velocity in ventricles
10. What extra activity do type IA antiarrhythmics have? What are the three drugs?
 K+ blocking in ventricles => slow repolarization and longer plateau
 Quinidine, procainamide, and disopyramide
[QUeeN DISO’s PYRAMID of coCAINe]
11. What is special about quinidine, or rather, especially bad (4 things)? How can this be partially
fixed with other drugs?
 Anticholinergic effect=> increased conduction through AV node=> ventricular fibrillation in
people with atrial fibrillation; 1:1 A:V firing ratio is established in contrast to former 2:1 or 4:1
 Use β-adrenergic antagonists or verapamil
 Other side effects are torsades de pointes, powerful diarrhea, nausea, headache, and
dizziness, the last four make it hard for patients to take long term
 Increases blood levels of digoxin
12. What are the adverse effects of procainamide?
 Eventually produces a Lupus-like syndrome, and has active metabolite NAPA with class III
effects: prolongs QT interval and refractory period
13. What is the major drawback of disopyramide? When should it be avoided? Special app?
 Even worse anticholinergic effects than quinidine: do not administer to those with
obstructive uropathy, glaucoma, conduction block, sinus node dysfunction, or
decompensated HF
 hypertrophic obstructive cardiomyopathy, we dunno why
14. What is the added effect of IB antiarrhythmics? What is another useful feature? 3 drugs?
 shorten repolarization
 Use-dependent block; greatest effect on cells firing more frequently, little effect on normal
cardiac tissue
 Lidocaine, mexiletine, and phenytoin
[LIDdy’s PHamous MEXIcan]
15. When is lidocaine used? When should you adjust the dose? Main location of adverse effects?
 Ventricular arrhythmias in emergencies
 Give less to patients with poor liver flow or inhibited P450 enzymes
 CNS effects: confusion, dizziness, and seizures
i. notably free of long QT syndrome
16. What drugs is mexiletine usually combined with (3)? When is phenytoin used?
 Amiodarone, in patients with implantable cardioverter-defibrillators (pacemakers) and Vtach
 Quinidine or sotalol to increase efficacy and reduce adverse effects
 Phenytoin is great for children with ventricular arrhythmias, esp. prolonged QT and after
congenital heart surgery
17. How do class IC drugs change the action potential? 3 drugs?


Markedly decrease the rate of phase 0 upstroke of ventricular cells
i. Suppresing ventricular contractions, plus supraventricular contractions
Flecainide, encainide, and moricizine
[MORtuary FLECks ENCased, all have a “c”]
18. What are class IC drugs’ major drawbacks? When may they be used?
 Sinus node dyfunction, decreased conduction velocity, and conduction blcok
 Approved only when other measures fail, in life-threatening situations
19. How do β1 antagonists affect the action potentials of SA and AV nodes? What receptor
subtypes does propanolol work on? How about labetalol and carvedilol? What are class II
adverse effects?
 Lengthens SA nodal depolarization (phase 4); Lengthens AV nodal repolarization (phase 3)
[LAVeNdeR & SAND at the βeach]
 Nospecific antagonist for β1 or β2
 β1 antagonists, α antagonists too
i. most others are just β1 antagonists
 β2-antagonist-induced vasospasm: cold extremities, impotence; “overdose:” negative
inotropy, heart block; CNS penetration: insomnia, depression
20. What are the big positive and negative of class III antiarrhymics? What’s another general
negative?
 K+ blocking prolongs repolarization and plateau:
i. Increases refractory period, and decreasing re-entry
ii. Increases likelihood of afterdepolarizations and so torsades de pointes
 All except amiodarone show reverse use-dependency 
21. When is ibutilide used? What is its serious adverse effect?
 Terminate atrial fib and flutter
 Torsades de pointes, like all drugs with class III activity
22. Dofetilide:
 Oral only; only used for highly symptomatic atrial fib and flutter because of its potential to
cause arrhythmias
23. What class is sotalol? Uses?
 Mixed II and III
 Ventricular arrhythmia, atrial fluter and fibrillation
24. How do you classify bretylium? What drug and intervention should you try first?
 Class III and antihypertensive agent
 Only used after lidocaine and defibrillation have failed to treat V tach or fibrillation
25. Which drug has activity akin to all classes of antiarrhytmics? What are its 2 uses? Major side
effects? What is its shady friend?
 Amiodarone; alters the lipid membrane
 Preventing ventricular arrhymias in patients with HF or MI, preventing paroxysmal atrial
fibrillation or flutter


Pneumonitis=> pulmonary fibrosis; hyper/hypothyroidism; α-antagonist=> hypotension
Dronedarone, mostly untrustworthy
26. What is the major therapeutic action of class IV drugs? Which have greater activity in vascular
smooth muscle, and which in the atria?
 They slow conduction through the AV node
 Dihydropyridines like nifedipine
 Verapamil and diltiazem treat Afib and SVT
i. Note that these guys are also sometimes used in V tach
27. What drug opens G protein-coupled K+ channels, limits conduction, and treats paroxysmal
supraventricular tachycardia as a first line agent?
 adenosine
28. What’s a great drug for chronic refractory angina pectoris?
 Ranolazine
 Biochem 47 crossover: inhibits partial fatty acid oxidation (pFOX) after an ischemic episode
and prevents buildup of lactic acid
This isn’t relaly necessary now
Afib
quinidine, disopyramide, encainide2, flecainide2, moricizine2, ibutilide, dofetilide, amiodarone,
dronedarone, verapamil, diltiazem
SVT
quinidine, disopyramide, encainide2, flecainide2, moricizine2, amiodarone, adenosine,
verapamil, diltiazem
PACs quinidine
PVCs quinidine, procainamide, disopyramide, lidocaine? phenytoin? sotalol? Bretylium?
VT
procainamide, disopyramide, encainide, flecainide, moricizine, amiodarone, lidocaine
Vfib
lidocaine? phenytoin? sotalol? amiodarone
Hypertension, angina, & HF
B-blockers, diltiazem, verapamil
Quinidine
moricizine
flecainamide
ibutilide
dronedarone
lidocaine
procainamide
disopyramide
bretylium
amiodarone
mexiletine
encainamide
phenytoin
dofetilide
sotalol
all drugs in the IC class have one “c”